Dec 06, 2023 / 02:00PM GMT
Operator
Good afternoon, and thank you for joining us today for Vivoryon conference call to discuss the company's third quarter of 2023 results and operational progress. This morning Vivoryon issued a press release reporting its third quarter 2023 results, which is posted on the company's website at www.Vivoryon.com.
On the call with me today are Vivoryon's Chief Executive Officer from Veeva; and Florian Schmid, our Chief Financial Officer. Also with us on today's call and available for questions is Michael Schaeffer, our Chief Business Officer.
We will begin today's call with opening remarks from [Frank Weber] clinical research and operational progress. Then Florian will review the financial results for the third quarter of 2023, and I will walk you through our key catalysts, including remarks. Following the prepared remarks, it will host a Q&A session.
Frank Weber Vivoryon Therapeutics N.V.-CEO - Chief Medical Officer
Yeah.
Operator
Q3 2023 Vivoryon Therapeutics NV Earnings Call Transcript
Dec 06, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers